Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Phys Act Health ; 20(4): 303-310, 2023 04 01.
Artigo em Inglês | MEDLINE | ID: mdl-36854312

RESUMO

Albert Einstein taught us that "everything is relative." People's experience of physical activity (PA) is no different, with "relativism" particularly pertinent to the perception of intensity. Markers of absolute and relative intensities of PA have different but complimentary utilities, with absolute intensity considered best for PA guideline adherence and relative intensity for personalized exercise prescription. Under the paradigm of exercise and PA as medicine, our Technical Note proposes a method of synchronizing accelerometry with the incremental shuttle walking test to facilitate description of the intensity of the free-living PA profile in absolute and relative terms. Our approach is able to generate and distinguish "can do" or "cannot do" (based on exercise capacity) and "does do" or "does not do" (based on relative intensity PA) classifications in a chronic respiratory disease population, facilitating the selection of potential appropriate individually tailored interventions. By synchronizing direct assessments of exercise capacity and PA, clearer insights into the intensity of PA performed during everyday life can be gleaned. We believe the next steps are as follows: (1) to determine the feasibility and effectiveness of using relative and absolute intensities in combination to personalize the approach, (2) to determine its sensitivity to change following interventions (eg, exercise-based rehabilitation), and (3) to explore the use of this approach in healthier populations and in other long-term conditions.


Assuntos
Tolerância ao Exercício , Exercício Físico , Humanos , Acelerometria/métodos
2.
BMJ Open ; 11(9): e053189, 2021 09 23.
Artigo em Inglês | MEDLINE | ID: mdl-34556518

RESUMO

INTRODUCTION: Music and dance are increasingly used as adjunctive arts-in-health interventions in high-income settings, with a growing body of research suggesting biopsychosocial benefits. Such low-cost, low-resource interventions may have application in low-resource settings such as Uganda. However, research on perceptions of patients and healthcare professionals regarding such approaches is lacking. METHODS: We delivered sample sessions of music and dance for chronic respiratory disease (CRD) to patients and healthcare professionals. Seven participants took part in one singing and dance sample session. One patient completed only the dance session. We then conducted an exploratory qualitative study using thematic analysis of semistructured interviews with healthcare professionals and patients regarding (1) the role of music and dance in Ugandan life and (2) the perceived acceptability and feasibility of using music and dance in CRD management in Uganda. RESULTS: We interviewed 19 participants, made up of 11 patients with long-term respiratory conditions and 8 healthcare professionals, who were selected by purposeful convenience sampling. Four key themes were identified from interview analysis: music and dance (1) were central components of daily life; (2) had an established role supporting health and well-being; and (3) had strong therapeutic potential in respiratory disease management. The fourth theme was (4) the importance of modulating demographic considerations of culture, religion and age. CONCLUSION: Music and dance are central to life in Uganda, with established roles supporting health and well-being. These roles could be built on in the development of music and dance interventions as adjuncts to established components of CRD disease management like pulmonary rehabilitation. Through consideration of key contextual factors and codevelopment and adaptation of interventions, such approaches are likely to be well received.


Assuntos
Música , Atenção à Saúde , Gerenciamento Clínico , Humanos , Pesquisa Qualitativa , Uganda
5.
BMC Pulm Med ; 17(1): 179, 2017 Dec 08.
Artigo em Inglês | MEDLINE | ID: mdl-29216852

RESUMO

BACKGROUND: Equitable access to affordable medicines and diagnostic tests is an integral component of optimal clinical care of patients with asthma and chronic obstructive pulmonary disease (COPD). In Uganda, we lack contemporary data about the availability, cost and affordability of medicines and diagnostic tests essential in asthma and COPD management. METHODS: Data on the availability, cost and affordability of 17 medicines and 2 diagnostic tests essential in asthma and COPD management were collected from 22 public hospitals, 23 private and 85 private pharmacies. The percentage of the available medicines and diagnostic tests, the median retail price of the lowest priced generic brand and affordability in terms of the number of days' wages it would cost the least paid public servant were analysed. RESULTS: The availability of inhaled short acting beta agonists (SABA), oral leukotriene receptor antagonists (LTRA), inhaled LABA-ICS combinations and inhaled corticosteroids (ICS) in all the study sites was 75%, 60.8%, 46.9% and 45.4% respectively. None of the study sites had inhaled long acting anti muscarinic agents (LAMA) and inhaled long acting beta agonist (LABA)-LAMA combinations. Spirometry and peak flow-metry as diagnostic tests were available in 24.4% and 6.7% of the study sites respectively. Affordability ranged from 2.2 days' wages for inhaled salbutamol to 17.1 days' wages for formoterol/budesonide inhalers and 27.8 days' wages for spirometry. CONCLUSION: Medicines and diagnostic tests essential in asthma and COPD care are not widely available in Uganda and remain largely unaffordable. Strategies to improve access to affordable asthma and COPD medicines and diagnostic tests should be implemented in Uganda.


Assuntos
Corticosteroides/provisão & distribuição , Agonistas Adrenérgicos beta/provisão & distribuição , Asma/tratamento farmacológico , Técnicas de Diagnóstico do Sistema Respiratório/estatística & dados numéricos , Acessibilidade aos Serviços de Saúde , Antagonistas de Leucotrienos/provisão & distribuição , Antagonistas Muscarínicos/provisão & distribuição , Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico , Administração por Inalação , Corticosteroides/economia , Corticosteroides/uso terapêutico , Agonistas Adrenérgicos beta/economia , Agonistas Adrenérgicos beta/uso terapêutico , Albuterol/economia , Albuterol/provisão & distribuição , Albuterol/uso terapêutico , Antiasmáticos/provisão & distribuição , Antiasmáticos/uso terapêutico , Asma/diagnóstico , Combinação Budesonida e Fumarato de Formoterol/economia , Combinação Budesonida e Fumarato de Formoterol/provisão & distribuição , Combinação Budesonida e Fumarato de Formoterol/uso terapêutico , Combinação de Medicamentos , Custos de Medicamentos , Combinação Fluticasona-Salmeterol/economia , Combinação Fluticasona-Salmeterol/provisão & distribuição , Combinação Fluticasona-Salmeterol/uso terapêutico , Humanos , Antagonistas de Leucotrienos/economia , Antagonistas de Leucotrienos/uso terapêutico , Antagonistas Muscarínicos/economia , Antagonistas Muscarínicos/uso terapêutico , Doença Pulmonar Obstrutiva Crônica/diagnóstico , Testes de Função Respiratória , Espirometria , Uganda
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA